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Abstract
Life without energy flow is impossible. Thermodynamically, an organism is a system maintained in a nonequilibrium steady state by energy expenditure, permitting it to reduce its own entropy at the expense of
the environment (Morowitz, 1968; Wallace, 2010). Mitochondria are the major source of energy in the
eukaryotic cell. They convert the chemical energy of ingested hydrocarbons into the high-energy bond of
adenosine triphosphate (ATP). This is accomplished by the combination of electron flow through the
electron transport system (ETC), the generation of an electrochemical gradient across the mitochondrial
inner membrane, and the use of the resulting potential energy to generate ATP. The mitochondrial inner
membrane electrochemical gradient can also be used to generate electromagnetic energy (Maxwell,
2013) and heat energy to sustain the body temperature. In order to maintain order at the expense of
energy, organisms require systems to store and access information. Deoxyribonucleic acid (DNA)
polymers allow information storage in the form of genes (HERSHEY and CHASE, 1952; WATSON and
CRICK, 1953) which are present in the mitochondria (Attardi, 1985; M. M. NASS and S. NASS, 1963; S.
NASS and M. M. NASS, 1963) and the nucleus. In the nucleus, DNA is wound around proteins called
histones which in turn can be altered in structure and function by post-translational modifications
(methylation, acetylation, phosphorylation, etc). In this thesis, mitochondrial energy production and
genetic information storage and retrieval are discussed. The effect of mitochondrial DNA on nuclear
information system is revealed and a model of how mutations in mtDNA can cause human disease is
proposed.
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ABSTRACT

MITOCHONDRIAL DNA REGULATION OF NUCLEAR EPIGENOME
Piotr K. Kopinski
Douglas C. Wallace

Life without energy flow is impossible. Thermodynamically, an organism is a
system maintained in a non-equilibrium steady state by energy expenditure, permitting it
to reduce its own entropy at the expense of the environment (Morowitz, 1968; Wallace,
2010). Mitochondria are the major source of energy in the eukaryotic cell. They convert
the chemical energy of ingested hydrocarbons into the high-energy bond of adenosine
triphosphate (ATP). This is accomplished by the combination of electron flow through the
electron transport system (ETC), the generation of an electrochemical gradient across
the mitochondrial inner membrane, and the use of the resulting potential energy to
generate ATP. The mitochondrial inner membrane electrochemical gradient can also be
used to generate electromagnetic energy (Maxwell, 2013) and heat energy to sustain the
body temperature.
In order to maintain order at the expense of energy, organisms require systems
to store and access information. Deoxyribonucleic acid (DNA) polymers allow
information storage in the form of genes (HERSHEY and CHASE, 1952; WATSON and
CRICK, 1953) which are present in the mitochondria (Attardi, 1985; M. M. NASS and S.
NASS, 1963; S. NASS and M. M. NASS, 1963) and the nucleus. In the nucleus, DNA is
wound around proteins called histones which in turn can be altered in structure and
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function by post-translational modifications (methylation, acetylation, phosphorylation,
etc).
In this thesis, mitochondrial energy production and genetic information storage
and retrieval are discussed. The effect of mitochondrial DNA on nuclear information
system is revealed and a model of how mutations in mtDNA can cause human disease
is proposed.
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PREFACE

A scientist and, for that matter, a physician, is generally expected not to write on
a topic or treat a patient in a field of which he is not the true master. However, a
pediatrician may save an adult’s life. This is particularly desirable when in absence of the
better qualified specialist no help would be given at all. While I could only wish to have
been a physicist, I am compelled to attempt bridging the gap between the physicist’s and
molecular biologist’s approach to understanding human health and disease, even at the
risk of making a fool of myself (Morowitz, 1976), because I believe application of
physical principles to biomedical science will generate new knowledge useful for
medicine. Luckily no particular life is at stake here, except perhaps my scientific one.
Of this, a good example is the discovery of polonium and radium by Maria
Skłodowska-Curie and their application to oncology. However, since few of us make a
breakthrough discovery of the kind Professor Skłodowska made, we must find other
ways to advance this cause.
In this vein, while the quest to understand how life began has not yet provided a
definite answer, it did manage to describe features of life which are necessary for its
existence. In simple terms, life requires energy flow and information storage systems.
These two systems are inextricably intertwined and it is their coordinate function that
makes life possible. There are likely many mechanisms of such coordination and this is
my attempt to describe one.
So much for my apology.
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Chapter 1. Mitochondria: Genome, Metabolism, Health
Mitochondrial genome evolution necessitates communication systems
The mitochondrial genome consists of ~ 1,300 nuclear-coded mitochondrial
genes and 500-1000 copies per cell of the 16,569-base pair (bp) mitochondrial DNA
(mtDNA). While the nuclear DNA (nDNA) codes for the majority of the mitochondrial
protein genes, the mtDNA retains genes encoding rRNAs, tRNAs and 13 critical proteins
for mitochondrial energy generating system oxidative phosphorylation (OXPHOS)
(Wallace, 2018).
The eukaryotic organism arose as the result of an endosymbiosis of an aerobic
prokaryote and an archeobacterium (Margulis, 1982) (sometimes referred to as the Last
Eukaryotic Common Ancestor (LECA)). This was advantageous because the presence
of multiple proto-mitochondria producing energy allowed the generation of excess
energy which permitted sustaining more nuclear genetic information. Since
microorganisms readily transfer genes and the transfer of genes from the protomitochondrion to the proto-nucleus reduced the number of gene copies from hundreds
distributed across the proto-mitochondria to only two in the proto-nucleus, this was
advantageous since it resulted in energy savings. Greater information capacity at lower
energy expense per unit of information allowed more complex cells and ultimately
multicellular organisms to arise (Wallace, 2018; 2013).
It is generally thought that the progressive transfer of genes from the protomitochondrion to the proto-nucleus occurred over a billion years (Wallace, 2013).
Ultimately, the fungal-animal mtDNA lineage retained only 13 polypeptides, all critical
components for OXPHOS. Therefore, it is possible that either mitochondrial DNA genes
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were retained because their transfer no longer imparted sufficient energetic advantage,
or alternatively that the mtDNA genes that were retained permitted multiple copy
intracellular regulation of energy metabolism without requiring short term modulation of
the limited copy nuclear DNA genes (Wallace et al., 2007). However, the transfer of
proto-mitochondrial genes to the proto-nucleus resulted in a physical distancing between
genes of related function. This necessitated the evolution of a communication system
which allowed mitochondrial and nuclear cooperative function (Wallace, 2010; Wallace
and Fan, 2010)
Since mtDNA is inherited exclusively from mother to offspring via the hundreds of
thousands of mitochondria found in the oocyte (Case and Wallace, 1981; Giles et al.,
1980), maternal and paternal mtDNAs never mix or recombine. It is possible that
recombination between the energy genes of the mtDNAs was deleterious, thus their
preservation on a separate non-recombining mtDNA molecule was advantageous
(Sharpley et al., 2012). The non-recombining mtDNA genes remain in total linkage
disequilibrium. Hence, these genes must coevolve over many generations (Wallace,
2015). Finally, mtDNA mutation rate is an order of magnitude greater than that of nuclear
DNA (W. M. Brown et al., 1979; 1982; Neckelmann et al., 1987), possibly due to
increased exposure to reactive oxygen species, polymerase errors, and inefficient repair
mechanisms (Harman, 1972; Kujoth et al., 2005; Trifunovic et al., 2004). This would
cause increased genetic diversity within a species, thereby increasing its chances of
adapting to variation within the environment. For example, in endothermal animals, the
allocation of mitochondrial energy to ATP production versus heat production to maintain
body temperature is mutually exclusive. Hence, this relationship must be shaped by
selection pressure from the environment. An animal living in the tropics would benefit
2

from having most of its mitochondrial energy directed to ATP production while and
animal living in the arctic would need to allocate more mitochondrial energy to heat
production to resist cold stress. This differential can be modulated by changing the
efficiency by which the burning of dietary calories is converted into the electrochemical
gradient and the electrochemical gradient is converted to ATP, known as the coupling
efficiency (Ruiz-Pesini et al., 2004; Wallace, 2015).
Mitochondrial DNA content
mtDNA is a circular molecule including a G-rich heavy strain (H) and a C-rich
light (L) strand which can be separated on alkaline cesium-chloride gradients (Welter et
al., 1988; Zimmerman et al., 1988). The heavy strand encodes 12 protein genes, the Lstrand 1. There is one regulatory region, also known as control region, which is
hypervariable in sequence and contains the H-strand origin of replication (OH) and both
the H-stand and L-strand promoters (PL and PH). The L strand origin (OL) is located 2/3
around the mtDNA circle in the direction of H-strand replication. Replication initiates at
OH and proceeds around the circle along the L-strand template to OL displacing the
parental H-strand. Replication of the L-stand then initiates and proceeds back along the
displaced H-strand resulting in bidirectional asynchronous DNA replication. All of the
enzymes for mtDNA replication and transcription including polymerase γ (POLG) and
mitochondrial RNA polymerase are nuclear-coded (Holt and Reyes, 2012; Yasukawa
and Kang, 2018).
MtDNA contains three promoters for transcription: PH1, PH2, and PL. PH1 (heavy
strand 1) promotes transcription of rRNA, PH2 (heavy strand 2) transcribes the entire H
strand and PL (L strand) of the entire L strand (Montoya et al., 1981; 1997; Ojala et al.,
1981). To initiate transcription, mitochondrial RNA polymerase (POLMT) and
3

mitochondrial transcription factors A, B1, and B2 assemble at the promoters (Uchida et
al., 2017). The mRNA transcript is polycistronic, the transcripts cut into functional RNAs,
frequently around separating tRNAs. The exact mtDNA transcription mechanism is still
actively investigated (Falkenberg et al., 2007; Taanman, 1999).
Little is known about mitochondrial RNA translation. Mitochondrial DNA encodes
2 rRNAs for the mitochondrial ribosome and 22 tRNAs required for mitochondrial protein
synthesis (Table 1). However, all of the polypeptides for the mitochondrial ribosomes
and the translation factors are coded by the nucleus. These include the mitochondrial
initiation factors 1 and 2 (mtIF2, mtIF3) which control the initiation of translation (Gaur et
al., 2008), initiate translation with formyl-methionine, elongation factors (TUFM, TSFM,
and GSM1) (Hammarsund et al., 2001; Ling et al., 1997), and all of the aminoacyl-tRNA
synthetases. Aminoacyl-tRNA is directed to the acceptor (A) site by TUFM-GTP
complex, where the tRNA pairs with the codon site. GTP hydrolysis allows peptide bond
formation. TUFM is released, the complex is reestablished by TSFM. GSM1 causes
release of the deacetylated tRNA from the peptidyl site (P), translocation the peptidyltRNA from the A to P, and from P to exit site (E). The ribosome then advances on the
mRNA by one codon (Cai et al., 2000). Termination is signaled by a stop codon at the A
site (D’Souza and Minczuk, 2018).
The mtDNA genetic code has diverged from that of the universal genetic code.
The mtDNA lacks a tRNA for the arginine codons, AGA and AGG, suggesting that they
act as stop codons. Both ATG and ATA can code for methionine, TGA is used for
tryptophan, and UGG is a mtDNA stop codon (Anderson et al., 1981). Thus,
mitochondrial protein synthesis requires coordination of expression of both mtDNA and
nDNA-encoded mitochondrial genes.
4

Nucleotide Position
577-647
1602-1670
3230-3304
4263-4331
c(4329-4400)
4402-4469
5512-5579
c(5587-5655)
c(5657-5729)
c(5761-5826)
c(5826-5891)
c(7446-7514)
7518-7585
8295-8364
9991-10058
10405-10469
12207-12265
12266-12336
c(14674-14742)
15888-15953
c(15956-16023)

tRNA
Phe
Val
Leu (1)
Ile
Gln
Met
Trp
Ala
Asn
Cys
Tyr
Ser (1)
Asp
Lys
Gly
Arg
Ser (2)
Leu (2)
Glu
Thr
Pro

Table 1. mtDNA-encoded tRNAs. C – complement
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The 13 polypeptides encoded in the mtDNA include essential subunits of the
electron transport chain (ETC) and the ATP synthase. For the ETC complexes, the
mtDNA codes for 7 (ND1-4, ND4L, ND5-6) of the 45 subunits of NADH-ubiquinone
oxidoreductase (Complex I), one (cytochrome b) of the 11 subunits of ubiquinolcytochrome c oxidoreductase (Complex III), and three (COI-III) of the 13 subunits of
cytochrome c oxidase (Complex IV). The four subunits of succinate-Q reductase
(Complex II) are all nuclear-encoded. The mtDNA also coded for two (ATP6 & 8) of the
18 subunits of the ATP synthase (Wallace, 2018). Therefore, in order to maintain proper
stoichiometry between the complexes and their subunits, mtDNA and nDNA expression
need to be regulated in concert.

Recently it has been discovered that the mtDNA codes for significantly more
polypeptides than the 13 OXPHOS subunits. These polypeptide genes are encoded
within the larger genes and have hormonal and gene regulatory functions. The two best
characterized are Humanin located within the 16S rRNA (Lee et al., 2016; 2013; 2015)
and MOTS-c within the 12S rRNA gene (Kim et al., 2018). Since the mtDNA is
symmetrically transcribed, it is also probable that the mtDNA mRNAs are subject to
micro-RNA regulation.

Energy metabolism: glycolysis and tricarboxylic acid cycle
The mitochondria process dietary hydrocarbons through fatty acid β oxidation,
carbohydrates such as glucose from glycolysis through pyruvate via the tricarboxylic
acid cycle (TCA or Krebs Cycle) and amino acid via degradation pathways including the
branched-chain alpha-keto acid dehydrogenase complex. These hydrocarbons serve as
electron donors for the ETC of OXPHOS.
6

Glucose undergoes glycolysis in a series of steps summarized in the following reaction:
Glucose + 2 Pi + 2 ADP + 2 NAD+ → 2 Pyruvate + 2 ATP + 2 NADH + 2 H+ + 2 H2O
Thus, 1 mole of glucose yields 2 moles of pyruvate. When oxygen is not available,
pyruvate is reduced to lactate and oxidizing NADH to regenerate NAD+ allowing
glycolysis to continue:
Pyruvate + NADH + H+ → Lactate + NAD+
When oxygen is available, pyruvate is oxidized to acetyl-CoA:
Pyruvate + CoA + NAD+ → Acetyl-CoA + CO2 + NADH
This reaction is irreversible, since CO2 will diffuse into solution and be exchanged in the
lungs for oxygen. This reaction is a key sink for pyruvate, ensuring acetyl-CoA is not
reduced to pyruvate and that TCA intermediates are preserved even if glycolysis
converts most of the pyruvate to lactate. The mutually exclusive fate of pyruvate results
in the following approximation:
Glucose → 2 Lactate – n mitochondrial Acetyl-CoA
In other words, if glycolysis did not branch and no decarboxylation of pyruvate occurred,
for each mole of glucose consumed by the cell we should detect two moles of lactate
produced. Since lactate is extruded from the cell, particularly in culture, this
measurement provides a convenient way of quantifying the proportion of pyruvate that is
decarboxylated on entering the TCA cycle.
Mitochondrial Acetyl-CoA undergoes aldol condensation with oxaloacetate
followed by hydrolysis, catalyzed by citrate synthase to yield citrate. This reaction is
7

energetically favorable, which contributes to the ease of citrate detection relative to
acetyl-CoA detection in metabolomic experiments. Acetyl-CoA contributes two carbons
to the 4-carbon oxaloacetate, for a total of 6 carbons.
Citrate, like pyruvate, has alternative fates. One is to continue through the TCA
cycle. The other is to be exported into cytoplasm by mitochondrial citrate carrier (CIC).
When continuing in the cycle, citrate is isomerized by aconitase to isocitrate. Citrate is a
prochiral molecule, causing aconitase (OGSTON, 1948) to reconfigure the molecule so
that in the subsequent reactions the carbons originating from acetyl-CoA are not
released into solution as CO2. Therefore, isocitrate dehydrogenase will catalyze
formation of alpha-ketoglutarate and CO2, removing the first carbon that originated from
acetyl-CoA and yielding a 5 carbon compound. Alpha-ketoglutarate can also be
introduced into the TCA cycle by the metabolism of glutamine, glutamate, proline,
arginine and histidine. In case of glutamine, glutaminase, through a hydration and
deamination, generates glutamate. Glutamate dehydrogenase then converts glutamate
to alpha-ketoglutarate by oxidation and deamination, yielding NADH and ammonia.
Thus, while citrate can bifurcate to continue in the cycle or leave, alpha-ketoglutarate
either comes from citrate or amino acids.
Alpha-ketoglutarate undergoes oxidation and another decarboxylation (another
CO2 released leaves the four-carbon compound with no carbons remaining from the
acetyl-CoA) by incorporating a molecule of Coenzyme A (CoA) at the expense of one
NAD+. The resulting succinyl-CoA undergoes phosphorylysis and the phosphoryl group
is transferred to GDP forming GTP. Succinyl-CoA synthase releases the CoA to
generate succinate.
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Succinate undergoes dehydrogenation by succinate dehydrogenase (SDH),
transferring two protons to FAD to yield FADH2 and producing fumarate. Fumarate is
hydrated by fumarase to form malate, which is then oxidized by malate dehydrogenase
to yield NADH and oxaloacetate. Thus, the TCA cycle oxidizes two carbons to CO2,
reduces 3 NAD+ to NADH and reduces on FAD to FADH2 with the regeneration of
oxaloacetate.

Energy metabolism: electron transport system
Glycolysis and the TCA cycle transfer reducing equivalents to NADH + H+ and
FADH2. The hydrogen associated with NADH is oxidized by complex I to NAD+ and used
to reduce coenzyme Q10 (CoQ) and the hydrogen associated with FADH2 is oxidized by
CoQ. In the ETC, electrons flow through complex I, CoQ, complex III, cytochrome c,
complex IV, to O2 to generate H2O. As electrons traverse the ETC, protons are pumped
out across the mitochondrial inner membrane at complexes I, III, and IV. This builds the
proton gradient which serves as a source of potential energy to drive ATP synthase to
condense ADP + Pi to ATP (Wallace, 2018) (Wallace, et al. 2017).
In addition to multiple polypeptides, some nDNA coded and other mtDNA coded,
the OXPHOS complexes encompass an array of co-enzymes critical for charge
transport. NADH is oxidized by complex I, the electrons initially transferred from NADH
to flavin mononucleotide (FMN) and down through a series of complex I sulfur (FeS)
centers to the lipid soluble electron carrier CoQ (Wallace et al., 2007).
The crystal and Cryo-EM structures of NADH-Ubiquinone oxidoreductase (NADH
dehydrogenase alias complex I) has been solved, but the mechanism by which electron
9

flux through complex I to CoQ is coupled to the transport of protons across the inner
membrane is still actively being investigated. An important feature of coupling of
electron transport to proton pumping involves the transfer of electrons from the terminal
FeS center, N2, to CoQ which is approximately 200 Å away. This requires the
conformation change of the complex. The flux of the 2 electrons through complex I from
NADH to CoQ results in the transport of four proton across the mitochondrial inner
membrane (T. J. Jeon et al., 2018).
CoQ can carry two electrons, being converted from ubiquinone to ubisemiquinone to ubiquinone with the successive addition of the two electrons. Electrons can
be contributed to CoQ via FADH2 from complex II, from fatty acid oxidation via the
electron transfer flavoprotein, and well as several other dehydrogenases including
dihydroornitine dehydrogenase which transfers electrons to CoQ during the conversion
of dihydroorotate to orotate in de novo pyrimidine biosynthesis (Wallace et al., 2007).
Succinate-ubiquinone oxidoreductase (succinate dehydrogenase alias Complex
II) transports electrons from the TCA cycle intermediate succinate to CoQ. This enzyme
encompasses and FAD, and FeS center, a b-like cytochrome, and a CoQ binding site
encompassed within its four nDNA coded polypeptides. It is the only TCA cycle enzyme
which forms part of the electron transport system, but it does not pump protons across
the membrane (Wallace et al., 2007).
Ubiquinol:cytochrome c oxidoreductase (the bc1 complex alias Complex III)
encompasses two cytochrome b subunits, a cytochrome c1 subunit, the Rieske FeS
protein, and two CoQ binding sites encompassed within its 11 polypeptides. It oxidizes
ubiquinol to ubiquinone, transmits the electrons through the two cytochrome bs and CoQ
sites in what is called the Q cycle, and shuttles the electron out through the Rieski FeS
10

center and cytochrome c1 to cytochrome c. Cytochrome c carries one electron at a time.
In the process, complex III pumps out two protons.
The cytochromes are Fe-containing porphyrins (hemes) whose different side
chains and associated polypeptides have different redox potentials. These transport
electrons toward the more oxidized end of the ETC.
Cytochrome c:oxygen oxidoreductase (cytochrome c oxidase alias complex IV) is
the final step of the ETC. Complex IV encompasses two copper centers and two
cytochromes a + a3 within its 13-polypeptide structure. It collects the electrons from four
cytochrome cs and reduces on O2 to generate 2 H2Os, pumping four protons in the
process.
Finally, the H+-pumping ATP synthase (ATP synthase alias complex V) uses the
electrochemical gradient generated by the ETC to generate ATP by rotary catalysis. The
ATP synthase couples proton flux back into the mitochondrial matrix with ATP synthesis
by a rotary catalysis system, the proton gradient spinning a wheel inside the inner
membrane that rotates an axial which penetrates a tripartite barrel of three α and β
subunit pairs. As the axial spins within the barrel it alters the conformation of each αβ
pairs causing first the binding of ADP + Pi, then their condensation to ATP, and then
release of the ATP, such that one ATP is generated for each 120-degree rotation of the
wheel (Wallace et al., 2007).

11

Mitochondrial DNA mutations and disease states
Since the mtDNA codes for 13 key polypeptides required for Complexes I, III, IV,
and V plus the rRNAs ad tRNAs for mitochondrial protein synthesis to express these
polypeptides, deleterious mutations in the mtDNA can perturb mitochondrial OXPHOS
and thus diminish mitochondrial and cellular energy production. The first report that a
deleterious missense mutations could cause an inherited mitochondrial disease was a
mutation in the ND4 gene at nucleotide position 11778 G>A causing conversation of the
arginine 340 to histidine (ND4 m.11778 G>A R340H) which causes the maternally
inherited blindness, Leber Hereditary Optic Neuropathy (LHON) (Wallace et al., 1988a).
The first report of an inherited deleterious protein synthesis mutation was the tRNALys
m.8344 A>G mutation associated with Myoclonic Epilepsy and Ragged Red Fiber
(MERRF) disease (Shoffner et al., 1990; Wallace et al., 1988b). Subsequently, a
mtDNA tRNALeu(UUR) m.3243 A>G mutation was reported to cause the Mitochondrial
Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) syndrome (Goto et
al., 1990).
There are three classes of clinically relevant mtDNA mutations: recent
pathogenic mutations, ancient adaptive polymorphisms, and somatic mutations. Recent
pathogenic mutations are maternally inherited and can be either pure mutant
(homoplasmic) as is the case of the ND4 m.11778 G>A mutation causing LHON, or a
mixture of mutant and normal mtDNAs (heteroplasmy) as is the case for the tRNALys
m.8344A>G and the tRNALeu(UUR) m.3243A>G mutations. Generally the homoplasmic
mtDNA mutations generate stereotypical phenotypes while the heteroplasmic mtDNA
mutations when at different heteroplasmic percentages give variable mitochondrial
energy deficiency and markedly different clinical manifestations (Wallace, 2018).
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Ancient mtDNA polymorphisms are homoplasmic and transmitted matrilineally
over many generations. A set of lineage-defining ancient mtDNA variants in descendant
mtDNA molecules known as a haplogroup. Haplogroups have been shown to be
founded by one on more functional mtDNA variants which are thought to have imparted
a selective advantage to individuals with that mtDNAs in a particular environment. For
example, individuals living in the tropics would benefit from having very efficient tightly
coupled mitochondria and thus minimized heat production. By contrast, individuals living
in cold climates would benefit from having less efficient mitochondria which would
expend more of the energy as heat, so these populations acquire a different array of
functional mtDNA variants (Ruiz-Pesini et al., 2004; Wallace, 2015). While functional
mtDNA variants can be beneficial in one environment they may be deleterious in
another. This is thought to be the reason for the homoplasmic tRNAGlu m.4336 A>G
mutation that arose in Europe about 10,000 years ago forming haplogroup H2a and
which now increases the risk of late-onset Alzheimer and Parkinson disease (Shoffner et
al., 1993). Similarly, various European haplogroups predispose to autism (Chalkia et al.,
2017) and certain Asian mtDNAs predispose to diabetes, obesity and hypertension
(Chalkia et al., 2018).
Finally, somatic mtDNA mutations accumulate with age and erode mitochondrial
function over time. This constitutes the aging clock and accounts for the delayed onset
and progressive course of the common metabolic and degenerative disease (Wallace,
2018).
Importantly, these three classes of mtDNA mutations coexist in any given cell
and produce variable phenotypes depending on their combination. The best example of
this is the Leber’s mutation, which causes blindness when on haplogroup H, but results
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in much more severe pontine cerebellar atrophy when present on haplogroup J (M. D.
Brown et al., 1997; 1995; Carelli et al., 2002). Thus, it is important to consider the
implications of the context in which mtDNA variation occurs.
While the idea that mtDNA mutations cause a variety of diseases in humans is
now accepted, very little is known about the mechanism by which mutations in mtDNA
can cause such a variety of phenotypes. This is best exemplified by the strikingly
different clinical manifestations of the tRNALeu(UUR) m.3243A>G mutation associated with
different percentages of mutant heteroplasmy. This same mutation when present in the
body at 10-30% of cell mtDNA it is associated with Type I and II diabetes and in some
cases autism; at 50-90% with neurodegenerative disease, myopathy and
cardiomyopathy, as well as MELAS; and at 100% with lethal multisystem disease in
infants (Picard et al., 2014). Despite recent characterization of biochemical effects of the
mutation on tRNA function in protein synthesis (YaMing Hou, personal correspondence),
there is currently no explanation for the variety of phenotypes caused by this
heteroplasmic mtDNA mutation.
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Chapter 2. The nuclear epigenome information system
Organization of information is required for life
In eukaryotes, storage, propagation, and access to information is largely enabled
by nuclear DNA. Human nDNA contains about 3 x 109 base pairs (bp) per haploid
genome (n), for a total of over 6 Gb per nucleus of a cell. The nucleus is a doublemembraned compartment of the cell with diameter ranging from 2-10 μM.
The total length of DNA per nucleus is estimated at about 2 m. The nuclear
genome encodes about 20,000 protein-coding genes, 14,000 pseudogenes, as well as
long-noncoding (15,000), small non-coding (5,000), micro- (1500), ribosomal (500),
small nuclear (2000), small nucleolar (1500) and other non-coding (2000) RNA
sequences. It is difficult to estimate what proportion of the genome is functional. One
measure of this is the proportion of nucleotide bases subject to selective pressure, which
is estimated between 10-20% (Ponting and Hardison, 2011). Interestingly, all cells
contain sequence encompassing the total genetic information, even though in a mature
organism cells are distinct from each other and form tissues of different function. It has
been shown that tissue-specific cells exhibit distinct gene expression profiles and that
even within a tissue (e.g. bone marrow), cells at various stages of development express
different genes. Thus, nDNA must be accessed selectively to allow specialized function.
This presents an organizational challenge, how to determine the correct genes to be
transcribed in different cell types from among all of the genomic loci. In addition, during
cell division, the entire nDNA-encoded portion of the genome is condensed into higher
order structures known as chromosomes, which decondense after the division is
complete. In the condensed chromosomal state, transcription of nDNA is generally
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suppressed and reinstated after decondensation. Therefore, chromatin emerges as an
essential component of information organisation.

Chromatin allows organization and regulation of access to nuclear information
Chromatin is the complex formed by nDNA and proteins. In the metaphase of cell
division, chromatin is visible in the form of chromosomes, in which all the nDNA is
condensed to allow orderly segregation and passage on to the daughter cells
(Flemming, 1965). When not dividing, chromosomes are decondensed, allowing protein
interactions which lead to expression of genes. However, even in decondensed form,
chromatin is organized. Microscopically, chromatin organization in a non-dividing
nucleus is visualized as euchromatin and heterochromatin, euchromatin seen as lighter
due to lesser compaction compared to highly compact heterochromatin. Generally,
heterochromatin is associated with transcriptional repression (Klemm et al., 2019). In
prokaryotes, only euchromatin is present, suggesting that heterochromatin coevolved
along with the development of the eukaryotic nucleus to enable selective access to
information as the nuclear genome size increased.
On the molecular level, the chromatin fibre is composed of DNA and histone
proteins. DNA is double stranded and forms a double helix (WATSON and CRICK,
1953) which is wound in 147 bp sections around histone cores forming the nucleosome.
This is accomplished by the DNA being wrapped or “spooled” around the histone core.
Two copies of each histone: H2A, H2B, H3, and H4 form the eight-component core.
Histones H1/H5, known as linker histones, are associated with DNA outside the
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nucleosome. Thus, histones are important for proper nucleosome spacing, and help
stabilize the chromatin fibre by binding other proteins (Berezney and K. W. Jeon, 1995).
In an active chromosome, the fibres form loop domains. This requires the
presence of a specific DNA sequence which allows binding of the CCCTC-Binding factor
(CTCF). When CTCF is bound in two places, the fibre between the two binding sites can
be extruded through a ring structure formed by the cohesin protein complex, akin to
when a needle is thread. Once the CTCF-binding sequence complexes reach the
cohesin ring, the extrusion cannot proceed further, stabilizing the loop. The mechanism
of loop extrusion and stabilization is currently under investigation. However, it is known
that the cohesin complex composed of structural maintenance chromosomes (SMC)
proteins 1, 3, and RAD21 has ATPase activity (Rowley and Corces, 2018) and that cells
depleted of ATP are unable to re-establish CTCF loops (Vian et al., 2018).
Functionally, chromatin organization can be characterized by HiC experiments, in
which neighbouring loops of DNA are cross-linked, then cut away and sequenced. The
sequences can then be aligned to the genome, exposing spatial proximity of sequences
distant to each other by linear nucleotide sequence. By HiC, DNA sequence interaction
is visualized by a pyramid-shaped interaction frequency plot, where the base represents
sequences most often interacting, with relative frequency of interaction decreasing away
from the base. In this scheme, the smallest and most frequent interactions are called
Topologically Associated Domains (TADs) and are represented by the darkest triangles
at the pyramid base, where the darker the shading the more frequent the interaction.
Multiple TADs can lie within a larger compartment. Some TADs as well as larger
compartments are stabilized by CTCF loops (Rowley and Corces, 2018).
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Domains not flanked by CTCF are called ordinary domains. A single CTCF loop
can span both actively transcribed (“active”) and inactive compartmental domains, or
only one or the other. It is currently known that 3D chromatin organization influences the
transcriptional state of genes and vice versa. The model of chromatin organization and
its relationship to transcriptional regulation is an area of active investigation.

Chromatin as sensor of energy states
Histones which form the nucleosome core are small, highly conserved proteins
(Allis and Jenuwein, 2016). They extrude tails containing residues modifiable by adding
functional groups, including CH3CO- (acetyl), CH3- (methyl), as well as -PO32(phosphoryl), and others (Bannister and Kouzarides, 2011). Covalent modification of
histones can occur at approximately 600 post translational modification sites (Li et al.,
2018). The two most abundant modifications are acetylation and methylation, which
mostly occur on lysine (K) residues (methylation can also occur on arginines). Generally,
each lysine residue can accept either one acetyl group or up to three methyl groups.
Histone lysine acetylation is catalysed by a family of enzymes known as histone
acetyl transferases (HATs) which transfer the acetyl group from acetyl-CoA to lysine to
form ε-N-acetyllysine. Since the original discovery of the first histone acetyltransferase in
Tetrahymena (Brownell et al., 1996), multiple HATs have been identified. These include:
1) GCN-related N acetyltransferases (GNATs) like GCN5; 2) MYST-related HATs like
Moz and Tip60, 3) p300/CBP HATs, and others. Each HAT exhibits variable substrate
specificity for histones, including H3, H4 and H2A ((Brownell et al., 1996) (Grant et al.,
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1999) (Y.-M. Kuo and Andrews, 2013) (M. H. Kuo et al., 1996; Suka et al., 2001),
however, all of them require acetyl-CoA as a substrate.
Histone deacetylation is catalysed by histone deacetylases (HDACs). There are
multiple HDACs categorized into 5 classes (I, IIa, IIb, III, IV) which operate through
various mechanisms in different cellular compartments. Notably, sirtuins 1 and 2, which
belong to the class III HDACs which require NAD+ for deacetylation. Thus, the steady
state of acetylation is maintained by competing processes of acetyl group deposition and
removal. Importantly, the acetyltransferases (HATs) and deacetylases (HDACs) show
different substrate specificities for particular histone residues in in vitro experiments. The
exact characteristic of each enzyme and its specificity in vivo is an area of active
investigation.
Histone lysine methylation is facilitated by methyltransferases. Lysine-specific
methyltransferases include set-domain containing (e.g. SET, SETD2), and dot-like (e.g.
DOT1L) enzymes. Over 20 different methyltransferases have been described and many
are highly substrate specific for a given histone residue. However, all require Sadenosylmethionine (SAM) to transfer a methyl group onto the lysine. SAM is a
metabolite in one-carbon metabolism, which requires mitochondrially generated methyl
groups and ATP to be generated. Notably, methylation and acetylation of many histone
lysines is competitive (Meier, 2013).
In addition to histones, the DNA strand can also be modified by methylation on
the 5-carbon on cytosine residues yielding 5-methylcytosine (5mC). 5mC is oxidized to
from 5-hydroxymethylcytosine, then to 5-formylcytosine, and finally to 5carboxylcytosine. This process also requires SAM, but is facilitated by DNA19

methyltransferases (DNMTs). While there are multiple genes coding multiple isoforms of
DNMTs, the most abundant human DNMT is DNMT1, which has the highest activity at
hemimethylated DNA. By contrast, DNMT3a and DNMT3b are equally active with
unmethylated and hemimethylated DNA as the substrate. In general, DNA methylation is
associated with transcriptional repression (Li et al., 2018).
Demethylation of histones is facilitated by lysine-specific histone deacetylases 1
and 2 (LSD1/2) as well as JumanjiC (JmjC) family of histone demethylases. Both LSD 1
and 2 require FAD, while JmjC demethylases require α-ketoglutarate for activity and are
inhibited by succinate, fumarate and other structurally similar compounds. DNA
demethylation is facilitated by ten-eleven translocation (Tet) proteins. Like JmjC, they
require α-ketoglutarate.
The chromatin acetylation and methylation modification state is the product of
competitive reactions between depositing and removing the modification. This process
is also affected by the deposition and removal of other modifications as well as
chromatin accessibility and substrate amount. During DNA replication new histones are
required and must be modified to maintain cell appropriate gene regulation.
Thermodynamically, the favourability of acetylation/deacetylation or
methylation/demethylation reactions depend on the free energies of each reaction as
well as concentration of substrates: acetyl-CoA, NAD+, (SAM and αKG for
methylation/demethylation) and the appropriate histone residue (modified or unmodified
(unmod)). While enzyme catalysis does not impact the reaction direction, it allows for a
lower activation energy. Thus, removal of enzyme units carrying out the forward reaction
will result in a shift of the steady state towards the reverse reaction. By extension,
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removal of substrate may differentially impact particular residues due to different enzyme
affinities.
Finally, for proper nucleosomal arrangement and spacing, ATP-dependent
chromatin remodelling enzymes are essential. They encompass the SWI/SNF and ISWI
complex and they require ATP to reposition nucleosomes. The mechanism of ATPdependent remodelling is an area of active investigation, but little is known of the impact
of energy deficiency on ATP-dependent remodelling in vivo.
Thus, chromatin serves to organize information and is affected by metabolic
processes which involve changes of substrate/cofactor concentration.

Chromatin state influences gene expression
How particular chromatin states influence gene transcription is the major
question of a whole area of science. Generally, acetylation of histones promotes
transcription. Methylation of H3K4, H3K36, and H3K79 is associated with activation of
gene expression, while methylation of H3K9, H3K27, and H4K20 methylation are
associated with gene repression. The possibility of having anywhere from zero to three
methyl groups per lysine residue adds an additional layer of complexity. For example,
H3K27 di- (me2) and trimethylation (me3) are known to be associated with gene
repression and promoting heterochromatic state, while H3K27 monomethylation (me1)
has been positively associated with expressed genes (Wang et al., 2018). Interestingly,
demethylations from me3 to me2 and from me2 to me1 are catalysed by KDM4a (JmjC),
which require αKG, while LSD1/2 which requires FAD catalyses the me2 to me1 and me1
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to me0 reactions. Thus, specific metabolic states must promote specific chromatin states,
promoting specific transcriptional states.
In order for a gene to be transcribed, a protein complex containing RNA
polymerase must be formed around the promoter region. As the complex progresses
through the gene body, RNA is generated. However, gene transcription is additionally
regulated by enhancer regions which contain sequences binding additional proteins
which promote gene expression. While the promoter is a defined sequence immediately
preceding the gene body, enhancer sequences are brought spatially into the
transcriptional initiation complex to activate transcription even though they can be
located several thousand bp away from the promoter. Forced repositioning of an
enhancer of one gene can enhance transcription of another gene (Deng et al., 2012).
Importantly, histones present in different functional DNA regions (e.g. enhancer vs
promoter) are differentially modified. For example, H3K4me1 is associated with distal
enhancers, while H3K4me3 with active promoters. Thus, detailed chromatin state
description for all these variables becomes difficult, particularly genome-wide. However,
progress is being made due to advances in computing and genome-wide technologies.
Still, a complete model of how the effect of metabolic changes on gene transcription
through altered chromatin state exceeds current computing capabilities.

An Energetic Perspective
While the details of chromatin modifications and their relationship to
transcriptional control are complex, the substrates of all of the chromatin modification
processes have one thing in common, the energetic and metabolic status of the
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mitochondrion. The energy for DNA replication, RNA transcription, and protein
translation as well as many post-translational modifications all require mitochondrial
ATP. The intermediates that modulate the histone and DNA modifications (acetylCoA,
α-ketoglutarate, succinate, SAM) are all directly or indirectly derived from the
mitochondrion. Hence, mitochondrial physiology must be an important factor in
modulating the structure of the epigenome and the resulting transcriptional profile. The
experimental component of my thesis was to demonstrate that this is the case.
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Chapter 3. Mitochondrial regulation of the nuclear epigenome
Hypothesis
mtDNA mutations alter mitochondrial metabolism and cause a variety of clinical
phenotypes associated with changes in gene expression. Since chromatin structure is
modulated by enzymes using mitochondrial metabolic substrates, mtDNA variation
should influence the epigenome. Therefore, I have tested the hypothesis that the
mechanism by which changes in the mtDNA genotype affect cellular and organismal
phenotypes is through modification of nuclear gene expression via changes in
mitochondrial metabolites that influence histone modifications.

Approach
To examine this hypothesis, a suitable model system is required. Such a system
ideally has: 1) defined mtDNA variation with sufficient functional characterization to know
the effect of the mtDNA genotype on the cells and the health of the organism, 2) limited
nuclear DNA variation to eliminate confounding variables from nuclear mutations, and 3)
capacity to permit biochemical experiments under specified conditions. For this purpose,
I used the mtDNA m.3243 A>G tRNALeu/UUR mutation transmitochodrial cybrid cell model
system in which a variable mtDNA heteroplasmic genotype correlates with a strikingly
variable phenotype. Patients harbouring the mtDNA 3243G mutation at ~20-40% mutant
present with Type II diabetes mellitus, at ~50-80% mutant with neurological symptoms
including the severe MELAS syndrome, and at 90-100% mutant manifest lethal pediatric
disease (Wallace, 2018). To generate a cybrid model for the 3243G mutation,
lymphoblastoid cells from a patient heteroplasmic for the m.3243A>G mutation (Heddi et
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al., 1993) were enucleated and the heteroplasmic cytoplasmic fragments (cytoplasts)
fused to the established human osteosarcoma cell line, 143B(TK-), which had been
cured of its resident mtDNA (ρ0) cells rendering these cells uridine-pyruvate-glucose
auxotrophs. Fusion of the patient cytoplasts restored mitochondrial function permitting
the resulting cytoplasmic hybrids (cybrids) to be selected for growth in medium without
uridine (Trounce et al., 1996). The resulting heteroplasmic cybrids were transiently
treated with ethidium bromide to reduce the mtDNA copy number and then cloned to
generate a series of cybrids with different proportions of the patient’s 3243G mutant and
3243A normal mtDNAs. Cybrids prepared with the 143B(TK-) nucleus are uniquely
stable for their percent mutant mtDNAs and cybrid clones were isolated with
approximately 0, 20, 30, 60, 70, 80, and 100% 3243G mutant mtDNAs. These cybrids
have been extensively physiologically characterized and their mRNAs isolated and
sequenced. The RNA sequencing revealed that the transcriptional profiles of the 0%,
the 20-30%, the 50-80%, and the 90-100% 3243G were each distinct, as if the gradual
increase in the percentage mutant mtDNAs resulted in abrupt phase changes in the
nuclear gene expression patterns associated with the distinctive patient phenotypes
(Picard et al., 2014).
Because of the unique features of the 143B(TK-) 3243A>G cybrids and the
patients with similar mtDNA genotypes, I set out to determine how continual graded
changes in the mtDNA heteroplasmy levels could result in the discontinuous phenotypes
and transcription profiles. The 143B(TK-) tRNALeu(UUR) m.3243A>G system is ideal for
studies of mitochondrial-nuclear interaction because the clinical genetics of the
3243A>G mutation is well studied and by starting with a heteroplasmic mtDNA donor,
the only difference in the mutant and normal mtDNAs is the single 3243A versus G base
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substitution. By using clones derived from and initial cybrid, the nuclear genes of the
difference cybrid lines should be as similar as is currently possible with cultured cell
systems. Finally, the tRNALeu/UUR m.3243 A>G mutation specifically inhibits
mitochondrial protein synthesis which affects cellular physiology, oxygen consumption,
cellular size and shape, and can be phenocopied by treatment with the potent
mitochondrial protein synthesis inhibitor chloramphenicol (CP) (Shay, 2013). Thus, the
3243A>G cybrid system is optimal for examining the effects of a quantitative increase of
mtDNA heteroplasmy on the epigenome.
In order to characterize the epigenomic state, several approaches were
considered. The ideal approach would provide a comprehensive characterization of as
many qualities of the epigenome as possible, including all the modifications, their
location in the genome, and their effect on the 3D structure and gene transcription.
Unfortunately, no one technique is capable of combining all three characteristics.
Chromatin immunoprecipitation (ChIP) is an antibody-based technique which when
combined with DNA sequencing (ChIP-seq) allows the location and quantification of
particular modified histones across the genome. However, it is an inherently biased
approach, since it requires a prior assumption on which histone modification should be
probed and is also limited by antibody availability and quality. HiC technology allows
characterization of the 3D structure by providing an interaction map of all the genomic
loci. However, it provides no specific information on the various covalent modification
states of the histones of DNA of the chromatin. Finally, bi-sulphite sequencing permits
determination of which CpG elements are methylated, but provides no information on
any other metabolic-epigenetic interactions nor 3D structure.
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Ultimately, the greatest breadth of information obtainable with a single
epigenomic modification technique is through the analysis of the full array of histone
modifications in response to different mtDNA genotypes and mitochondrial functions.
This can be accomplished by using liquid chromatography-tandem mass spectrometry
(LCMS) analysis of cybrid histone modifications. This histone analysis produces a
relatively unbiased characterization of over two hundred histone modification states with
clear quantitative output. This is advantageous since it was not known which
modifications would be affected by changes in mtDNA variation. Furthermore, changes
in histone modifications can be combined with metabolic tracer pathway analysis
permitting the monitoring of the journey of carbon atoms from the starting metabolite,
through the cellular metabolic pathways, to their ultimate deposition onto chromatin. This
is important since no prior direct evidence of mitochondrial metabolism affecting the
nuclear epigenome existed. Unfortunately, histone modification analysis is also limited
since it does not provide genomic localization of the specific histone modifications.
Therefore, I have used the array of 143B(TK-) m.3243A>G cybrid cell lines to
correlate changes in the mtDNA genotype with changes in the mitochondrial metabolites
and associated changes in the histone modifications. The mitochondrial metabolites
were identified and quantified using a variety for techniques while the histone
modifications were accessed by LCMS. The differences in metabolic and epigenomic
states due to the changes in mtDNA heteroplasmy were correlated with observed
changes in nuclear gene expression, thus providing insights into the pathophysiology of
mtDNA disease phenotypes.
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Methods
The mtDNA tRNALeu(UUR) nt 3243A>G mutation cybrids
Cell lines harbouring different percentages of the mtDNA tRNALeu(UUR) nt
3243A>G mutation were prepared by fusion of cytoplasts from a heteroplasmic mtDNA
tRNALeu(UUR) nt 3243A>G donor (Heddi et al., 1999) to human 143B(TK-) ρ0 cells
(Trounce et al., 1996). Transmitochondrial cybrid cell lines were maintained in DMEM
(4.5 g/L (25 mM) glucose + 110 mg/L sodium pyruvate (Gibco #10569)) supplemented
with 50 µg/ml uridine, non-essential amino acids (1:100, Gibco #11140), and 10% fetal
bovine serum (FBS), grown at 37oC in 5 % CO2 (Trounce et al., 1996).
Cybrid mtDNA tRNALeu(UUR) nt 3243A>G heteroplasmy levels were quantified by
PCR amplification of a 264 nt fragment surrounding the 3243 site and digestion with
HaeIII. The cybrid heteroplasmy levels were remarkably stable (Figure 1).
Cells for analysis of metabolites and histones were grown to approximately 80%
confluent in DMEM supplemented with 10% FBS, 1 mM glucose, 2 mM glutamine and
50 ng/L uridine (experimental media). For isotopic experiments, 13C-uniformly labeled
glucose or glutamine and dialyzed serum were employed.
Mitochondrial protein synthesis was inhibited with 100 μg/ml chloramphenicol
(CP) for 7 days (Wallace et al., 1975), with inhibition reversed by growth without CP for
three days. Complex I was inhibited with 1 μM rotenone for four hours.
Glucose and lactate consumption were analyzed by incubating cells for 4, 8, or
24 hours, the medium collected, the glucose and lactate measured using YSI 2950
Bioanalyzer, and the levels corrected for cell proliferation and media evaporation.
Oxygen consumption of digitonin permeabilized cells was analyzed using the Oroboros
instrument with 106 cells per ml in 2.2 ml of Miro5 buffer (0.5 mM EGTA, 3 mM
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MgCl2.6H20, 60 mM K-lactobionate, 20 mM Taurine, 10 mM KH2PO4 , 20 mM HEPES,
110 mM Sucrose, 1 g/L fatty acid free BSA, pH 7.0 with KOH). Substrates and complex
inhibitors were added as in Figure 2.
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Figure 1. Quantification and stability of mtDNA tRNALeu(UUR) nt 3243G heteroplasmy
monitored using restriction fragment polymorphism PCR.
A. Mixing of known quantities of 0% 3243G (wild type) and 100% 3243G mutant DNA
confirms relative accuracy of the RFLP method. B. Heteroplasmy quantification at 3
different time points that encompass the total number of passages which the
heteroplasmic cells have undergone during the duration of these experiments. The
143B(TK-) cybrid cell lines maintained under our culture conditions sustain surprisingly
stable heteroplasmy levels.
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Figure 2. Mitochondrial respiration of 0% 3243G cybrids cultured with and without
CP; A. Representative trace showing oxygen consumption in 0% 3243G cells with and
without inhibition of mitochondrial protein synthesis by CP; DGM – addition of digitonin
(10 µg/ml/2x106 cells) to permeabilize cell membrane, glutamate (final: 10 mM) and
malate (2 mM) (complex I substrates); ADP – addition of ADP (2.5 mM) to assess ATP
synthase coupled respiration; S – addition of succinate (10 mM) (complex II substrate) to
measure OXPHOS oxygen consumption through both complexes I and II; O – addition of
oligomycin (2.5 µM) to stop ATP synthase to measure proton leak rate; F – addition of
FCCP (F2 – 2 µl, F1 1 µl of 1 mM stock) to uncouple the electron transport from the ATP
synthase to determine maximal respiration; R – addition of rotenone (0.5 µM) to
measure complex II-driven maximal respiration; A – addition of antimycin A (2.5 µM) to
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block electron flow through complex III to assess non-mitochondria oxygen consumption;
B. Quantification of oxygen consumption: BASAL = respiration prior to addition of
chemicals to the chamber, OXPHOS I versus OXPHOS II = respiration after addition of
complex I or both complexes I and II substrates, respectively; relative to % 3243G
mutant respiration, the presence of 100% 3243G mutation partially inhibits respiration
while culture for seven days in 100 μg/ml CP results in complete inhibition of respiration,
the effects of which are reversed by three days culture without CP; Results shown as
mean with SD error bars, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns – not
significant, n = 3)
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Acetyl-CoA/free CoA, SAM, and organic acid measurement
Cells were cultured for 12 h in DMEM with 4.5 g/L glucose, 10% FBS, 50 μg/ml
uridine, 1 mM sodium pyruvate, 1x NEAA and 2 mM glutamine; harvested; and frozen
for 10 s in liquid nitrogen and stored in -80o C. The concentration of amino acids was
determined by Agilent 1260 HPLC system, utilizing precolumn derivatization with ophthalaldehyde (Nissim et al., 2014). Short-chain Acyl-CoAs and SAM levels were
determined by Agilent LC/MS 6410 Triple Quad system using 872-365 multiple reaction
monitoring (MRM) for Benzoyl-CoA (Internal standard); 868-361 MRM for Succinyl-CoA;
854-347 MRM for Malonyl-CoA; 838-331 MRM for Butyryl-CoA; 824-317 MRM for
Propionyl-CoA; 810-303 MRM for Acetyl-CoA; 768-261 for free CoA, and 399-250 MRM
for SAM. Organic acids levels were determined by the isotope-dilution approach and
GC-MS system (Weinberg et al., 2000).

Acyl-CoA and polar metabolite quantification and isotopologue analysis
Following 16 hours growth in normal media, cells were incubated in experimental
media containing labelled metabolites for 4 hours. For acyl-CoA quantification, the
attached cells were fixed by the addition of 1 ml of ice cold 10% (w/v) trichloroacetic
acid, harvested by scrapping, disrupted by pulse-sonication (sonic dismembrator, Fisher
Scientific), and the protein sedimented at 17,000 rcf for 10 mins at 4° C. Supernatants
were purified using Oasis HLB 1-ml (30 mg) solid-phase extraction columns (Waters),
conditioned with methanol and water. The supernatants were applied to the columns, the
columns washed with 1 ml H2O, the analytes eluted with methanol containing 25 mM
ammonium acetate, dried with N2 gas, and resuspended in 50 µl of 5% 5-sulfosalicylic
acid. For quantification, 0.1 ml of internal standard was added containing [13C315N1]33

labelled acyl-CoAs generated in pan6-deficient yeast culture (Snyder et al., 2015). All
other polar analytes were quantified after cell extraction with 80:20 methanol:water at 800 C, sonication, protein removal, drying with N2 gas, and resuspension in 5sulfosalicylic acid. Samples were analyzed using an Ultimate 3000 Quaternary UHPLC
coupled to a Q Exactive Plus mass spectrometer (Thermo Fisher Scientific) operating in
the positive ion mode (Frey et al., 2016; Guo et al., 2016). For 13C tracing experiments,
isotopic enrichment was calculated using the FluxFix online calculator (Trefely et al.,
2016).

Histone extraction and western blot analysis
For histone extraction, cells were switched to experimental media, washed with
ice-cold PBS, and 0.5 ml of Nuclei Isolation Buffer (NIB-250) added and incubated for 5
min. NIB-250 is 15 mM Tris-HCL (pH 7.5), 60 mM KCl, 15 mM NaCl, 5 mM MgCl2, 1
mM CaCl2, 250 mM Sucrose to which was added 1 mM dithiothreitol, 10 mM sodium
butyrate, 1 x Protein Inhibitor Cocktail (Sigma), and 0.1% NP-40 (Sigma). Cells were
harvested by scrapping, pelleted at 600 rcf for 5 min at 4° C, washed twice with NIB-250
without NP-40, and pelleted. Histones were extracted in 0.8 ml of 0.4 N H2SO4 for 2
hours at 4° C, the insoluble fraction pelleted at 11000 rcf for 10 minutes in 4 °C, and the
soluble fraction containing histones precipitated with 0.2 ml of 100% trichloroacetic acid
(TCA) at 4° C overnight. The film-like pellet of histone was sedimented at 11000 rcf for
10 min at 4 °C, washed with ice-cold 1 ml histone acetone with 0.1 % HCl plus two
washes in ice-cold pure acetone, air-dried and stored at -80° C for western blotting or
mass-spectrometry analysis.
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For western blotting, 0.5-1 μg of histone extract was electrophoresed on a
gradient 4-12 % Bis-Tris gel at 120 V for 60 minutes, and the proteins transferred onto a
0.2 cellulose membrane in methanol buffer overnight. Membranes were blocked in 5 %
dry milk, incubated in primary antibody (H4K5ac, H4) for 2 hours, washed thrice,
incubated with secondary horseradish-peroxidase conjugated antibody for 1 hour, and
peroxidase stained (Biorad Gel-Doc XR).

Histone modification quantification and isotopologue analysis
Histones were extracted from cells incubated in experimental media containing
labelled metabolites for 4 h. For mass-spectrometer analysis, histones were derivatized
using propionic anhydride, digested using trypsin, and the new N-termini also
derivatized. The resulting samples were stage-tipped and subjected to massspectrometer analysis using 0.1% formic acid in water and 0.1% formic acid in
acetonitrile as buffers, with separation carried out on a C18 column (Karch et al., 2016).
Data acquisition used high resolution DIA and the data processed using EpiProfile
software (Yuan et al., 2018).

NADH Fluorescence-Lifetime Imaging Microscopy (FLIM)
Fluorescence lifetime imaging microscopy of NADH (NADH FLIM) (Schaefer et
al., 2017) was performed on cells grown in glass bottom dishes (Greiner, 627870) with
the medium changed to Tyrodes buffer (pH 7.4) and the cells incubated for 4 h at 37°C
in room air. The cultures were then placed in the microscope chamber 15 min prior to
image acquisition, with FLIM imaged used a Zeiss LSM 710 laser scanning microscope
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equipped with a femtosecond pulsed two-photon laser (80 MHz, Coherent). NADH was
excited at 730 nm with a laser power of < 5 mW and fluorescence monitored using time
correlated single photon counting (HPM-100-40, Becker and Hickl) through a 680 nm
short-pass and 460/50 bandpass filter. Data was recorded using SPCM 9.77 and
subsequently analyzed using SPCImage 6.2 assuming a biexponential decay with fixed
τ1 = 400ps and τ2 = 2500ps for free and protein-bound NADH. Proper fitting of the
lifetime curve was evaluated using χ2 and the mean lifetime (τmean) was calculated.

Total cellular NAD+/NADH ratio measurement
NAD+/NADH levels were analyzed for cells grown for 12 h in DMEM with 4.5 g/L
glucose, 10% FBS, 50 μg/ml uridine, 1 mM sodium pyruvate, 1x NEAA and 2 mM
glutamine; then collected; and frozen for 10 s in liquid nitrogen and stored in -80o C.
Frozen pellets were resuspended in Tris buffer (pH = 8) and half extracted with
perchloric acid and half with alkaline buffer. After filtration, samples were loaded onto a
HPLC system using an YMC-Pack ODS-A column (5 μm, 4.6 × 250 mm) preceded by a
guard column. NAD+ and NADH peak areas were integrated by the Shimadzu
LabSolution software with standard curves normalized to protein (McCormack et al.,
2015).

RNA-sequencing data analysis
RNA-sequence data was used to determine expression levels of the NAD+
biosynthetic genes (Picard et al., 2014), reported as reads per kilobase per million reads
(RPKM) normalized to 0% m.3243G.
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Data analysis and statistical methods
R software (3.4.2) was used for metabolite-histone correlations; Spearman
correlation for correlating dependent variables across heteroplasmy spectrum; and
unpaired, two tailed, t-test (Prism software) for individual comparisons. For hierarchical
clustering, p-values were adjusted using the FDR method with false positive discovery
rate of 1%.

Results
Multiple relationships exist between mitochondrial metabolites and histone modifications
To determine the mitochondrial signals that may regulate the epigenome,
tricarboxylic acid (TCA) cycle intermediates were quantified across seven mtDNA
tRNALeu(UUR) nt 3243 A>G patient-derived cybrid lines with heteroplasmy levels of
approximately 0, 20, 30, 60, 70, 90, 100% m.3243G mutant, but with the same nuclear
DNA. The cybrid metabolite levels were then correlated with all nuclear histone
modifications assessed by liquid chromatography mass spectrometry (Figure 3). The
result was an extensive matrix of statistically significant correlations between
mitochondrially-generated metabolites and histone modifications across the
heteroplasmy spectrum (Figure 4) confirming broad spectrum control of nuclear histone
modifications by mitochondrial metabolism.
To test if the differential abundance of the mitochondrial metabolites causes the
changes in the histone modifications, two relationships were examined in detail: a
positive association between acetyl-CoA and histone H4 lysines 8 (H4K8) and 16
(H4K16) acetylation (ac) (Figure 4, blue square #1), and a negative association between
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the αKG/succinate ratio and histone H3 lysine 9 (H3K9) methylation (me) (Figure 4, red
square #2). The first association allowed direct examination of acetyl-CoA impact on
histone acetylation, since histone H4 tail residues (K5/K8/K12/K16) cannot be
methylated. The second association permitted analysing the effect of αKG level on
methylation, since αKG/succinate ratio correlated with H3K9 di- and trimethylation
(H3K9me2/3), but not H3K9 acetylation.
Strikingly, these two associations show different behaviours across the m.3243G
mutant heteroplasmy spectrum. Acetyl-CoA levels and H4K16 acetylation were stable
from 0% to 70% mutant mtDNAs, but then declined together at 90-100% mutant (R =
0.57) (Figure 4, bottom right). This decline was confirmed for all H4 residues in
independent experiments (Figures 5 and 6). By contrast, the αKG/succinate ratio was
low at 0% mutant, increased in 30-70% mutant, and declined again in 90-100% mutant
cells. The H3K9 di- and trimethylation showed the inverse pattern being high at 0%
mutant, low at 50-70% mutant, and high at 90-100% mutant (R = -0.45) (Figure 4A, top
right). αKG alone showed a similar pattern (Figure 7). The inverse αKG-histone
methylation association is expected since Jumonji C (JmjC) histone demethylases
known to be active on H3K9 require αKG to demethylate histones and are inhibited by
succinate (Carey et al., 2015).
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Figure 3. Methodology for analysis of heteroplasmy cell lines; Cells with various
degrees of heteroplasmy were cultured in parallel for histone and metabolite isolation
and quantification. The data was obtained from two different laboratories and correlated
using the Spearman method in R software. Associations are presented in color for p <
0.05. Positive correlations = blue, negative = red. Darker the color, the stronger the
correlation.
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Figure 4. Multiple metabolite-histone relationships are acting as mtDNA
heteroplasmy level increases; Seven mtDNA m.3243A>G heteroplasmic cell lines plus
the ρ0 parent cells were cultured in parallel for metabolite (j = 15) and histone
modification (i = 107) quantification by liquid chromatography tandem mass spectrometry
(LC-MS/MS). Spearman correlation coefficient was calculated for each histone
modification (unmod = unmodified peptide) against each metabolite, blue = positive, red
= negative, and blank = no correlation, with the colour intensity corresponding to
correlation strength (significance = p < 0.05). (Example #1, blue box) – positive
association between acetyl-CoA levels and histone H4 acetylation of lysines 8 (K8) and
16 (K16) across heteroplasmy levels; (Example #2, red box) – negative association
between αKG/succinate ratio and histone H3 lysine 9 di- (me2) and trimethylation (me3)
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across heteroplasmy levels. Each point represents a measurement and lines represent
local regression of the mean (R-software ‘loess’), n = 3.
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Figure 5. MtDNA genotype can be predicted from histone modification clustering;
A. Heatmap of histone acetylation modifications of 0 and 100% m.3243G lines (n = 3)
showing dramatic effect of mtDNA genotype on the histone epigenome; B. List of top 20
histone modifications ranked by p-value, showing the strong effect on mtDNA genotype
on H4K5, K8, K12, and K16 acetylation (n = 3). While it can be argued that modification
level changes at a particular site are not independent of either other changes at that site
or overall changes in the associated peptide, we also include p-values with an arbitrary
correction factor allowing a false discovery rate of 1% (adjusted p-value).
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Figure 6. Effect of mtDNA tRNALeu(UUR) nt 3243G heteroplasmy on histone
modifications; A. LC-MS/MS measurement of H4 acetylation from clustering
experiment shows decreased H4 acetylation on all residues; B. Representative image of
extracted histones Western blots reacted with antibodies to H4K5ac and H4 showing
decreased H4K5 acetylation normalized to total histone 4; C. Quantification of western
blots of H4K5ac/H4total (n = 6);
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Figure 7. Negative correlation of αKG levels with histone H3K9 trimethylation (left)
and H3K9 dimethylation (right); Each point represents a measurement and lines
represent local regression of the mean (R-software ‘loess’), n = 3)
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Mitochondria are the major source of citrate and acetyl-CoA
Since acetyl-CoA was significantly decreased in 100% mutant cells (Figure 4#1,
Figure 8C:right), but can be generated from multiple sources (Zhao et al., 2016), the
contribution of mitochondrial metabolism of glucose in the generation of acetyl-CoA and
acetylation of histone H4 was quantified. 0% and 100% mutant cells were incubated with
uniformly 13C -labelled glucose and the label traced through pyruvate, mitochondrial
generation and exportation to the cytosol of citrate, conversion of cytosolic citrate into
acetyl-CoA and oxaloacetate by ATP-citrate lyase (Wellen et al., 2009), and utilization of
the mitochondrially-derived acetyl-CoA for histone acetylation (Figure 9A). About 70% of
acetyl-CoA was derived from 13C-labelled. This was reduced to 45% in the 100% mutant
cell line (Figure 9B), since in 100% mutant cells much of the pyruvate was metabolized
to lactate thus limiting acetyl-CoA production (Figure 8A-C).
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Figure 8. Effect of mtDNA tRNALeu(UUR) nt 3243G heteroplasmy on pyruvate
metabolism, NADH accumulation, S-adenosylmethionine (SAM), and histone 4
acetylation; A. m.3243G-induced OXPHOS dysfunction shifts glucose metabolism
away from acetyl-CoA and toward lactate production due to NADH accumulation; B. In
an independent experiment, we quantified lactate production and intracellular acetyl-CoA
across all 3243G cell lines (0% heteroplasmy indicated by green, 100% by read spots),
revealing a strong inverse correlation between intracellular acetyl-CoA and lactate
production (n = 3; t = 12 h); C. Top left – For each mole of glucose consumed, 100%
mutant cells produce more lactate than 0% (wild type) counterparts (n = 3, t = 64 h,
corrected for cell proliferation); Top right – intracellular acetyl-CoA concentration is
reduced in 100% mutant cells compared to 0% (wild type) (n = 3); bottom left –
NAD+/NADH ratio measured by High Pressure Liquid Chromatography is lower in 100%
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mutant cells compared to 0% 3243G cells, n = 4; Bottom right – acetyl-CoA to free CoA
ratio, acetyl-CoA is reduced in 100% mutant cells (n = 3); D. S-adenosyl-methionine
concentration is decreased in 100% mutant cells; Results shown as mean with SD error
bars, * p < 0.05, ** p < 0.01, ns – not significant, n = 3)

47

Modulation of mitochondrial function can reversibly alter histone acetylation and
methylation
To confirm that decreased incorporation of glucose-derived 13C into acetyl-CoA
was due to the mitochondrial protein synthesis defect, the 0% m.3243G cybrid cells were
treated for seven days with CP to completely block mitochondrial protein synthesis of the
0% mutant cells. CP reduced the transfer of glucose-derived 13C into acetyl-CoA to ~2%.
Therefore, mitochondria are the major source of acetyl-CoA and impaired mitochondrial
protein synthesis limits mitochondrial acetyl-CoA production. This was confirmed by
wash out of CP resulting in the complete restoration of the incorporation of glucosederived 13C into acetyl-CoA (Figure 9B).
In parallel with the reduced mitochondrial incorporation of glucose-derived 13C
into acetyl-CoA, the effects of 100% mutant and CP on the acetylation of histone H4
(Figure 9C) were assessed. In the bi-colored bar graphs, the total bar height reflects
total histone acetylation levels. The different colored sub-bars represent the time-limited
incorporation of the 13C from the labeled precursor. Both the total steady state histone
H4 and 13C-glucose-derived H4 acetylation were decreased from 50% and 35% in 0%
mutant cells to 37% and 15% in 100% mutant cells, respectively (Figure 9C). When 0%
mutant cells were treated with CP, steady state H4 acetylation was decreased to 40%,
but the 13C-glucose-derived acetylation was eliminated. Following washout of CP, the
total steady state H4 acetylation returned to 50% and the glucose-derived 13C H4
acetylation returned to 35% (Figure 9C). Thus, impaired mitochondrial protein synthesis
caused by either 100% 3243G mutant mtDNAs or CP inhibition resulted in the depletion
of glucose-derived acetyl-CoA and in the reduction of histone H4 acetylation.
Mitochondrially-derived acetyl-CoA is thus the primary substrate for histone acetylation.
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Impairment of mitochondrial protein synthesis due to 100% m.3243G mutant
mtDNAs or CP inhibition should impair complex I and thus the mitochondrial oxidation of
NADH. The resulting decrease in NAD+ should stall the TCA cycle, reducing
mitochondrial production of αKG. Since αKG is the required substrate for the JmjC
histone demethylases (Tsukada et al., 2006), histone demethylation should be impaired
by a protein synthesis defect resulting in increased histone methylation (Figure 9D). Both
100% mutant and CP-treated 0% mutant cells showed decreased incorporation of
glucose-derived 13C into αKG, which was restored to normal in CP-treated 0% mutant
cells after CP washout (Figure 9E). Moreover, while 100% mutant cells did not show an
increase in H3K9 trimethylation, likely due to decreased SAM production (Figure 8D),
the 0% mutant cells treated with CP showed significantly increased levels of H3K9
trimethylation which returned to normal upon CP washout (Figure 9F). Thus, inhibition of
mitochondrial protein synthesis results in reduced αKG and leads to increased histone
methylation, presumably due to limiting JmjC histone demethylation.
To further evaluate the role of NADH oxidation and TCA cycle-mediated acetylCoA production, the effect of rotenone, a potent complex I inhibitor, on 13C-glucosederivation of acetyl-CoA was determined. Rotenone completely eliminated the
incorporation of glucose-derived 13C into acetyl-CoA (Figure 10A) and resulted in a
significant decrease in the steady state acetylation of H4 histone residues as well as
complete elimination of incorporation of glucose-derived 13C into H4 acetylation (Figure
10B, Figure 11C-F).
Because acetyl-CoA is essential, depletion of acetyl-CoA by rotenone inhibition
of complex I must be compensated. This could occur by the conversion of glutamine to
glutamate and then αKG, with αKG being converted to acetyl-CoA by either entering the
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TCA cycle to generate citrate or by reductive carboxylation (Wallace, 2012). When
labelling cells with glutamine-derived 13C, 0% mutant cells produced about 8% of the
acetyl-CoA from glutamine. However, after rotenone inhibition this rose to about 14%
(Figure 10C). In parallel, glutamine-derived 13C incorporated into H4 acetylation
increasing from about 14% in 0% mutant cells to about 21% following rotenone inhibition
(Figure 10D, Fig 11G-H). Thus, glutamine can make a small contribution to acetyl-CoA
for histone acetylation.
Rotenone not only depleted glucose-derived 13C incorporation into αKG (Figure
10E), but it also resulted in elevated levels of di- and trimethylation and in the di- and
trimethylation to monomethylation ratio of H3K9 (Figure 10F). Thus, mitochondrially
generated αKG must play a role in the activity of the JmjC histone demethylases.
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Figure 9. Mitochondria as key supplier of epigenetic metabolites. A. Mitochondrial
metabolism of 13C glucose to produce cytosolic acetyl-CoA; B. Conversion of 13Cglucose into acetyl-CoA in 0 (0) and 100% (100) m.3243G cells and in 0% cells treated
with CP (0+CP) without or with CP washout; C. Steady-state (total) histone 4 acetylation
(bar height) and 13C-glucose H4 acetylation (orange shading) in 0 and 100 %
heteroplasmy cells and 0% cells with CP ; D. Effect of CP and rotenone (Rot) on
complex I, the TCA cycle, αKG levels, and histone JmjC demethylation; E. Conversion of
13

C-glucose to αKG; F. Steady-state (total) histone 3 lysine 9 trimethylation; (CP

treatment and washout protocol as in Figure 2B)
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Figure 10. NADH:Q Oxidoreductase function is required for histone modifications.
A. 13C-glucose incorporation into acetyl-CoA in 0% mutant cells, without and with
rotenone (Rot) inhibition; B. Steady-state (total) (bar height) and 13C-glucose derived
(orange bar) H4 acetylation without and with Rot inhibition; C. 13C-glutamine
incorporation into acetyl-CoA without and with Rot inhibition; D. 13C-glutamine
incorporation into H4 acetylation without and with Rot inhibition; E. Conversion of 13Cglucose into αKG without and with Rot inhibition; F. H3K9 di- and trimethylation (left
panel) and poly/monomethylation ratio (right panel) of 0% cells without and with Rot
inhibition; G. Mitochondrial NAD+/NADH ratio determined by NADH lifetime in 0% cells
without and with Rot inhibition; * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, ns –
not significant, n = 3
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Figure 11. Effect of mtDNA tRNALeu(UUR) nt 3243G heteroplasmy, impaired
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mitochondrial protein synthesis and mitochondrial complex I inhibition on histone
H4 acetylation by residues; A. Steady-state levels of histone acetylation as fraction for
each lysine of histone H4 for 0% and 100% 3243G cells and for 0% cells treated with CP
and after CP washout; B. Proportion of acetylation on each histone H4 lysine derived
from 13C-labelled glucose for cell cultures as in A; C. Steady-state levels of histone
acetylation as fraction for each lysine of histone H4 for 0% and 100% 3243G cells and
for 0% cells after inhibition of complex I with rotenone; D. Steady-state levels of
unmodified, monoacetylated (ac1), diacetylated (ac2), triacetylated (ac3) or
tetraacetylated (ac4) histone H4 for cell cultures as in C; E. Proportion of acetylation on
each histone H4 lysine derived from 13C-labelled glucose for cell cultures as in C; F.
Proportion of acetylation derived from 13C-labelled glucose on mono and polyacetylated
histone H4 for cell cultures as in C; G. Proportion of glutamine-derived acetylation on
each histone H4 lysine for cell cultures as in C; H. Proportion of glutamine-derived
acetylation on mono and polyacetylated histone H4 for cell cultures as in C; Results
shown as mean with SD error bars, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001,
ns – not significant, A-B & E-H: n = 3, C-D: n = 6).
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mtDNA heteroplasmy causes distinct changes in NAD states in mitochondria and the
nucleus
NAD+/NADH ratio is crucial in regulating TCA metabolism and was reduced in
100% mutant cells (Figure 8C), but it is also known to vary between cellular
compartments. To assess sub-cellular levels of NAD+/NADH ratios, Fluorescence
Lifetime Imaging Microscopy (FLIM) was employed to quantify NADH lifetimes in the
mitochondria and the nucleus of the cybrid cell lines. By FLIM, decreased NADH lifetime
correlates with increased free NADH and decreased NAD+/NADH ratio (Schaefer et al.,
2017).
In the mitochondria, the NAD+/NADH ratio was relatively stable from 0% to 60%
heteroplasmy. It began to decline at 70% mutant and then dropped precipitously at 90
and 100% mutant (Figure 12A-B). Similarly, glucose-derived acetyl-CoA was sustained
in 0 to 70% mutant cells, but then dropped precipitously at 90-100% m.3243G mutant
heteroplasmy (Figure 12C). In parallel H4 acetylation was sustained up to 70% mutant
followed by a drop in H4 histone acetylation in the 90-100% mutant cells (Figure 12D &
E).
When impairment of mitochondrial protein synthesis reaches the level caused by
100% 3243G mutant, respiration is impaired (Figure 2), the mitochondria can no longer
oxidize NADH back to NAD+, the TCA cycle is inhibited, mitochondrial production of
glucose-derived acetyl-CoA is reduced, and histone acetylation limited. This limitation is
independent of glucose concentration in the media (Figure 13).
In the nucleus, the NAD+/NADH ratio declined sharply from that of the 0% mutant
cells, reaching a minimum in 20-60% mutant cells (Figure 14A-B). The nuclear
55

NAD+/NADH ratio then rose abruptly between 60 and 70% mutant cells to levels well in
excess to those of the 0% mutant cells. Finally, the NAD+/NADH ratio declined again at
100% mutant (Figure 14B). The sudden rise in NAD+/NADH ratio in the 60-70% mutant
cells correlated with the induction of genes for de novo NAD+ synthesis, starting at 30%
mutant, peaking at 70% mutant, and then declining to approximately the 0% level at
100% mutant (Figure 14C). The unusual behaviour of the nuclear NAD+/NADH ratio
exactly corresponds to the striking changes that occurred in the levels of the mtDNA
OXPHOS gene mRNAs (Figure 14D&E), suggesting that the nuclear NAD+ levels may
regulate the activity of the mitochondrial biogenesis genes. Nuclear NAD+ levels also
correlated with the phase changes in nDNA gene transcription seen between the 2030% versus the 60-90% mutant cells (Figure 15). The induction of NAD+ synthesis may
be a final attempt to reestablish a functional NAD+/NADH redox balance and stimulate
mitochondrial OXPHOS.
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Figure 12. Mitochondrial NADH lifetime regulates glucose incorporation into
acetyl-CoA and histone 4 lysine 16 acetylation. A. Pseudo-colored images of
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mitochondrial NADH lifetime analysis using FLIM across cybrid heteroplasmy levels; B.
Quantification of mitochondrial NADH lifetimes (NAD+/NADH ratios) across cybrid
heteroplasmy levels; C. Conversion of 13C-glucose into acetyl-CoA across cybrid
heteroplasmy levels; D. 13C-glucose incorporation into H4K6 acetylation across cybrid
heteroplasmy levels; E. Relationship between NADH lifetime (NAD+/NADH) and 13Cglucose conversion to acetyl-CoA and H4K16 acetylation showing strong correlation
across cybrid heteroplasmy levels (Spearman), n = 3.
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Figure 13. Histone acetylation changes due to m.3243A>G mutation are
independent of glucose concentration in the media; A. Glucose concentration
measurement after 4 h and 8 h incubation time of 0% (wild type) and 100% mutant cells
shows that 4 h incubation of 100% cells and 8 h incubation of 0% cells result in the same
glucose concentration in the media; B. Western blotting of H4K5 acetylation and total
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histone 3 (loading control) shows that 4 h 100% incubation and 8 h 0% incubation
results in different H4K5ac level despite the same concentration of glucose in the media
observed in A; C. Quantification of H4K5ac band intensity normalized to H3 total band
intensity shows decreased acetylation of H4 at lysine 5 in spite of same concentration of
glucose; media and histone extraction were carried out from the same plate for each
experiment, results shown as mean with SD error bars, * p < 0.05, ** p < 0.01, *** p <
0.001, ns – not significant, n = 3)
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Figure 14. Nuclear NADH lifetime correlates with mtDNA transcription and NAD+
biosynthesis gene induction. A. Pseudo-colored images mitochondrial NADH lifetime
analysis using FLIM across cybrid heteroplasmy levels; B. Quantification of nuclear
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NADH lifetimes (NAD+/NADH ratio) across cybrid heteroplasmy levels; C. mRNA levels
of key NAD+ de novo synthesis enzymes across cybrid heteroplasmy levels (NADSYN1
= NAD Synthetase 1 (rate-limiting), NMNAT1 = Nicotinamide Nucleotide
Adenylyltransferase 1, HAAO = 3-Hydroxyanthranilate 3,4-Dioxygenase, AFMID =
Arylformamidase); D. mtDNA mRNA levels across cybrid heteroplasmy levels
(reproduced from Picard, 2014); E. Parallel fluctuations of Nuclear NADH lifetime (black,
left axis), normalized NADH synthesis mRNA levels (blue), and normalized mtDNA
mRNA levels (red) across cybrid heteroplasmy levels; n = 3.
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Chapter 4. Mechanisms of transcription control by metabolite-epigenome
signals
Discussion
mtDNA regulation of the epigenome potentially explains transcriptional and phenotypic
variability of mitochondrial disease
The results presented suggest that mtDNA heteroplasmy can result in discrete
cellular transcriptional profiles and clinical phenotypes by simultaneously modulating
multiple metabolites key to epigenetic signalling (Figure 16). In contrast to wild-type 0%
mutant cells (Figure 16, State A), in the 20-30% tRNALeu(UUR) m.3243 A>G mutant cells, a
decline in the nuclear NAD+/NADH ratio is associated with a decline in mtDNA
transcripts and a switch from the 0% mutant transcriptional profile to that of the 20-30%
m.3243 A>G mutant cells (Figure 15 and 16, State B). This correlates with the chronic
mitochondrial energy deficiency observed in Type II diabetes (Petersen et al., 2003;
2004) and autism (Chalkia et al., 2017). In the 60-70% m.3243 A>G mutant cells, the
rise in nuclear NAD+ levels, corresponding to the induction of NAD+ synthesis, is
paralleled by an increase in αKG levels and a decline in histone methylation. This
correlates with the hyper-expression of the mtDNA genes and the transition to the next
discrete cellular transcriptional profile (Figure 15). This transcription profile corresponds
to neuromuscular degenerative disease manifestations and the KEGG-identified
transcriptional profiles of Alzheimer, Parkinson, and Huntington diseases (Figure 5D in
(Picard et al., 2014) and Figure 16, State C). Finally, in the 90-100% mtDNA tRNALeu(UUR)
m.3243 A>G mutant cells, the drop in acetyl-CoA levels in association with the decline in
histone acetylation is associated with a drop in mtDNA transcripts and the final transition
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in transcriptional profile (Figure 15 and 16, State D), this being associated with perinatal
lethal disease (Picard et al., 2014). Thus, increasing severity of the m.3243G mtDNA
genetic defect directly impacts mitochondrial metabolites and sub-cellular redox levels.
The metabolic changes cause discrete changes in the epigenomic state that correlate
with altered gene transcription and associated clinical manifestations.
Thus, the mitochondria regulate all three axes of covalent histone modifications
simultaneously, just like an orchestra conductor conducts all the instruments, modulating
their relative signal intensity at different times.
The regulation of nuclear epigenome by the mitochondrially-dictated metabolic
state is hardly surprising, considering the initial assumption that life is a process subject
to thermodynamic limitations established by gradients. The oxidation/reduction potential
differences between oxygen and reduced, electron-rich compounds (hydrocarbons,
carbohydrates, and proteins) establish a gradient used by life in the form of cellular
respiration. This is made possible by the reaction: ½ O2 + 2H+ → H2O serving as the
electron sink and the final step of respiration due to its highest standard reduction
potential (E0 = 0.82 V). Intermediates formed in the step reactions then establish
derivative gradients, which allow other reactions. Since enzymes are required to lower
activation energies to allow reactions to proceed at safe temperatures, their provision
needs to be regulated by coordinating information utilization and transmission. Hence,
chromatin covalent modifications and their function are a natural consequence of the
derivative gradients established by intermediate products of respiration.
Apart from basic physical principles, molecular biology provides some evidence
of this. In experiments reported here, the correlation between acetyl-CoA levels and
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histone acetylation was shown to be a causal relationship for glucose-derived acetylation
of histone H4. Since 13C-labelled carbons can only travel along biochemical pathways
(the naturally occurring 13C correction was applied), glucose-derived acetyl groups could
have only been deposited on histones having gone through mitochondrial metabolism. In
the genetic experiment, increasing levels of the mtDNA mutation affecting
NADH:ubiquinone oxidoreductase, ubiquinol:cytochrome C oxidoreductase, cytochrome
C oxidase and ATP-synthase were shown not to alter acetyl group derivation from
glucose and deposition on histones until the levels of the mutation reached critical
values (90-100%; Figures 4, 8B, and 12). The same result was obtained using cells
without mtDNA (Rho0). However, while 13C labelling allows to establish the direct link
between glucose metabolism through mitochondria and deposition of acetyl-CoA on
histones, it provided only a strong suspicion of causality. Therefore, two independent
pharmacological methods of mitochondrial respiratory system inhibition were employed.
Firstly, chloramphenicol, a well-established inhibitor of mitochondrial protein synthesis
was used to elicit similar phenotype to the genetic defect measured by cellular highresolution oxygen consumption (Figure 2). Importantly, at the dose used, cells were still
capable of cell division. Transient inhibition of mitochondrial protein synthesis prevented
any incorporation of glucose to acetyl-CoA and histones (Figure 4). Another chemical
with a different, but well-established mechanism of action, rotenone, which inhibits
electron transfer from iron-sulphur clusters to ubiquinone in NADH:ubiquinone
oxidoreductase (complex I) was used to validate this result. Simultaneous application of
rotenone in a non-lethal dose known to inhibit complex I and provision of 13C-glucose in
media culture prevented 13C incorporation into acetyl-CoA and histone acetylation
(Figures 10, 11). Thus, mitochondrial function is necessary for histone acetylation. By
washing out chloramphenicol from the culture and observing restoration of 13C
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incorporation into acetyl-CoA and histone acetylation, sufficiency was demonstrated. In
order to further establish sufficiency, cell lines with 100% G transduced with exogenous,
mitochondrially-targeted NADH oxidase which regenerates NAD+ from NADH thus
restoring NAD+/NADH ratio were established and showed rescued incorporation of 13C
glucose carbons onto histones, however, the results were preliminary (not shown) and
need further validation. This approach would also allow to rescue TCA cycle activity
without rescuing ATP-generation, which might produce interesting effects in chromatin.
Likely, while covalent modifications of chromatin may be re-established, loop extrusion
and nucleosome positioning could be adversely affected.
Regarding methylation changes as a result of mtDNA dysfunction causing
distinct alpha-ketoglutarate and succinate levels, the causal link demonstrated by
inhibition of mitochondrial protein synthesis with chloramphenicol (Figure 4) is well
documented in the literature (see the “Pathogenic nuclearly-encoded SDH mutations are
associated with transcriptional and phenotypic effects mediated by αKG-methylation
interaction” section). Since alpha-ketoglutarate is a substrate for the JmjC demethylases
and succinate an inhibitor, 13C experiments are of little use to establish directness.
However, tracing experiments are possible with S-adenosyl methionine, the universal
methyl group donor for all methylases and these efforts are already underway (Mentch
and Locasale, 2016).
As regards NAD+/NADH ratio, four observations were made utilizing the
localization ability of FLIM technology. Through the surrogate quantity of NADH lifetime,
mitochondrial NAD+/NADH ratio was shown to be decreased at 70% of heteroplasmy
and collapse at 90-100% (Figure 12). Secondly, the nuclear NAD+/NADH ratio changed
differently than mitochondrial and within a smaller range (Figure 14). The change in the
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mitochondrial NAD+/NADH ratio correlated with glucose incorporation onto histones,
which was in inhibited at 90-100% G as well as in 0% wild type cells treated with
rotenone. On the other hand, the nuclear NAD+/NADH ratio showed a pattern correlated
with changes in mtDNA transcription (Figure 14). This discrepancy between
mitochondrial and nuclear NAD+/NADH ratios provides an interesting insight into the
steady state of histone acetylation. In 100% cells, both mitochondrial and nuclear
NAD+/NADH ratios were reduced, yet histone acetylation was reduced. Therefore, the
mitochondrial NAD+/NADH ratio collapse and resulting lack of acetyl-CoA for acetylation
proved dominant over inhibition of deacetylation by sirtuins which require NAD+.
However, the concentrations of NAD+/NADH relevant for sirtuin function are still a matter
of debate. Additionally, as seen in images in Figure 14, the nuclear NADH lifetime shows
a multifocal pattern. Therefore, there may be local effects of NAD+/NADH concentrations
within chromatin on sirtuin activity (Aguilar-Arnal et al., 2016). Further studies are
required to better understand these relationships.
Apart from this study, other experiments have shown the relevance of
metabolism for the epigenome. For example, glycolysis rates have been linked to
histone acetylation maintenance. By inhibiting glycolysis using deoxyglucose, histone
acetylation steady state was moved to decreased acetylation (Cluntun et al., 2015).
Concurrently with this study, removal of mitochondrial DNA using ethidium bromide was
indirectly shown to decrease histone acetylation (Martínez-Reyes et al., 2016).
Additionally, a mitochondrial mutation in NADH:ubiquinone oxidoreductase was shown
to affect global NAD/NADH ratio and modulate T cell function (Angelin et al., 2017),
while nuclear mutation of ubiquinol:cytochrome c oxidoreductase was shown to
modulate alpha-ketoglutarate and succinate levels and affect function of T cells (S. E.
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Weinberg et al., 2019). Functionally, changes in intracellular alpha-ketoglutarate were
shown to alter histone methylation affecting pluripotency in mouse embryonic stem cells
(Carey et al., 2015), albeit indirectly, while acetylation changes were indirectly related to
induction of certain genes (L. Cai et al., 2011).
Regarding the effects of mtDNA heteroplasmy on gene transcription, the results
reported here are corollary. While clustering of transcription profiles by heteroplasmy
groups presenting with the same clinical phenotypes is strongly suggestive of causeeffect relationships and might satisfy probabilistic and statistical criteria used in genetics,
further experimentation is required to rigorously assess the effects of modulating mtDNA
heteroplasmy on gene transcription. The preferred approach would be combined
chromatin immunoprecipitation and RNA sequencing of parallel samples, which would
permit correlating chromatin state with transcriptional state. However, given the
multitude of chromatin modifications affected by mtDNA heteroplasmy, choice of the
relevant modification for immunoprecipitation may be challenging, especially while
seeking statistically meaningful relationships with as many as 7 different cell lines.
Notwithstanding, simpler experiments with rotenone and chloramphenicol are likely to
produce satisfactory results. Both these agents could also be fed to mice, and
chloramphenicol-saturated samples may even be obtained from previously healthy
individuals who succumbed to tularemia affecting the meninges, in whom
chloramphenicol is sometimes used. Additionally, a genetic approach using mice
heteroplasmic for two different DNA haplogroups or homoplasmic for complex I or IV
mutations is possible.
If confirmed, how transcriptional changes induce specific disease phenotypes in
humans is a key and highly complex question, as it requires consideration of tissue
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interactions with the processes described here at a cellular level. However, having
defined the key variables, such experiments are more likely to be successful and studies
of disease states in mice may prove particularly useful.
In summary, while this study provides evidence that mtDNA variation is capable
of inducing a variety of epigenetic states depending on the level of the heteroplasmy and
that in case of acetylation this is a direct effect of glucose metabolism through pyruvate
and citrate in the TCA cycle which requires electron transfer from NADH, it presents new
questions. First, where do the modifications now known to be altered by mtDNA variation
occur in the genome? Second, what is the effect of the mtDNA-sensitive modifications
on gene transcription at all loci? Third, how does the 3D chromatin structure change due
to mtDNA heteroplasmy? Finally, how does disease result from these changes? These
challenging questions will require substantial future efforts. However, as a result of this
study, we now have an opportunity for better characterization of the complex relationship
between energy flow and information systems in cells and higher organisms.
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Figure 15. Effect of mtDNA tRNALeu(UUR) nt 3243G heteroplasmy on nuclear gene
transcription. Whole cell transcriptional profiles determined by RNA-sequencing of
mRNA extracted from 0, 20, 30, 60, 70, 90, and 100% m.3243G heteroplasmic cybrid
lines plus parental 143B(TK-) ρ0 cell line, defined by three-way principal component
analysis. Clusters of cybrid cell lines transcriptional profiles harbor heteroplasmic levels
which correspond to those associated with distinct clinical phenotypes, printed in red
(reprinted from Figure 5C in (Picard et al., 2014)).
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Figure 16. Graphic representation of the changes in mitochondrial metabolites,
NAD+/NADH ratio, histone modifications, and gene expression profiles observed
in cybrid lines harboring increasing mtDNA tRNALeu(UUR) nt 3243G heteroplasmy
levels. The resulting associations suggest a model for the mitochondrial
regulation of the nuclear epigenome.
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Pathogenic nuclearly-encoded SDH mutations are associated with transcriptional and
phenotypic effects mediated by αKG-methylation interaction
Heritable succinate dehydrogenase mutations have been found to increase risk
of cancer (Rustin et al. 2002), in particular paragangliomas (Young et al. 2002),
pheochromocytomas (Neumann et al. 2002) (Maher and Eng 2002) gastrointestinal
stromal tumours (Stratakis and Carney 2009; Belinsky et al. 2013), renal cell carcinoma
(Ricketts et al. 2012) and neuroblastoma (Schimke et al. 2010). In sporadic breast
cancer, low expression of SDH isoforms A and B was correlated with younger age at
diagnosis and low grade histology (Kim et al. 2013). Both germline and somatic loss-offunction SDH mutations lead to decreased activity of SDH and accumulation of
succinate (Pollard 2005; Selak et al. 2005a). Moreover, loss of SDH is associated with
abnormal mitochondrial morphology (Douwes Dekker et al. 2003), increased levels of
reactive oxygen species, oxidative DNA damage, and genomic instability (Slane et al.
2006).
All α-KG-dependent dioxygenases, including EglN PHDs, the JmjC family, and
the Tet family share a common feature: they catalyze hydroxylation reactions in which
one atom of molecular oxygen is attached to and forms the hydroxyl group of the
substrate, while the other is taken up by α-KG leading to decarboxylation of α-KG and
release of CO2 and succinate. Succinate and fumarate are structurally similar to α-KG
and inhibit PHDs as well as JmjC and Tet enzymes (Epstein et al. 2001; Yu et al. 2001;
Isaacs et al. 2005; Selak et al. 2005b). Thus, inhibition of JmjC proteins should result in
altered histone modification patterns, while inhibition of Tet enzymes should have an
effect on DNA methylation.
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Indeed, both succinate and fumarate inhibit the activity of α-KG-dependent lysine
(histone) demethylases (KDMs) in vitro. The demethylation rate of synthetic lysine 9monomethylated histone 3 (H3K9me1) by KDM7A isolated from Caenorhabditis elegans
was substantially reduced (~80%) by adding milimolar concentrations of succinate and
fumarate (physiological concentrations ~0.5-1 mM and 100 µM, respectively; (Bennett et
al. 2009)). This inhibition is reversible by adding excess α-KG, suggesting a competitive
mode of inhibition, and is reproducible with synthetic H3K36me3 as a substrate for
human KDM4A. Succinate is a more potent inhibitor than fumarate in this in vitro system
(IC50 = 0.8 mM and 1.5 mM for succinate and fumarate, respectively (Xiao et al. 2012)).
Functionally, inhibition of SDH and FH result in increased H3K4 mono- and
trimethylation, and H3K27 and H3K79 dimethylation, 5mC hydroxylation, as well as
accumulation of HIF1a and decrease of endothelin in cell culture, indicating inhibition of
KDMs, Tet-2 enzymes, EglN PHDs, and collagen prolyl-4-hydroxylase, respectively. In
vivo, accumulation of succinate or fumarate also lead to a similar histone methylation
upregulation with concomitant increase of Hoxo factors associated with increased
H3K79me2. This result was recapitulated by knock-in of tumour derived SDH and FH
mutants into cultured cells (Xiao et al. 2012).
Independently, SDH inhibition induced increased H3K9me3, H3K27me3, and
H3K36me2 which was reversible by overexpression of JmjC3. This correlated with
decreased occupancy of the IGFPB7 promoter by the repressive H3K27me3 and
increased IGFPB7mRNA transcript level (Cervera et al. 2009).
In case of DNA methylation, succinate and fumarate were both shown to inhibit
Tet enzymes resulting in globally decreased 5mC and 5hmC levels (Xiao et al. 2012).
The global effect of SDH deficiency on chromatin landscape has been more precisely
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assessed at over 450,000 sites in a SDH-loss-of-function subtype of gastrointestinal
stromal tumours (GIST) and was found to have altered DNA methylation at multiple loci
when compared to non-SDH KIT-driven GIST samples (Killian et al. 2013). GISTs are
commonly associated with either KIT kinase pathway hyperactivation or metabolic
derangement due to SDH subunit mutations (Hirota et al. 1998; Pantaleo et al. 2011;
Janeway et al. 2011; Miettinen et al. 2013). While KIT-pathway mutant GIST
methylomes showed little divergence from methylomes of putative tissues of origin, that
was not the case for SDH-mutant GISTs, which were highly divergent from both KITdriven tumours and normal tissues of origin. This methylome divergence was also
observed in paraganglioma and pheochromocytoma samples. Both types of GISTs
showed similar degree of hypomethylation at CpG islands, but the SDH mutated GISTs
had a significant increase in methylation of CpG islands (CGIs). Hypermethylation at
CGI was also associated with hypermethylation in non-CGI regions including gene
promoters, bodies, and enhancers; these changes were proportionate to
hypermethylation at CGIs. By contrast, significant enrichment for non-CGI
hypermethylation was observed at DNase hypersensitive sites (DHS). Importantly, the
observed changes correlated with significant deficiency of 5hmC, consistent with failure
of Tet2-mediated demethylation of DNA. Interestingly, the SDH-mutant tumours had
remarkably stable genomes compared to KIT-mutants showing an inverse correlation
between karyotypic aberration and methylome divergence. This would suggest that
rather than leading to overall genomic instability through accumulation of secondary
mutations, SDH-deficient cells destabilize their genomes by deregulation of DNA
methylation.
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SDH-mutated paragangliomas (PGC) and pheochromocytomas (PCC) show
hypermethylation at both CGIs and non-CGI regions (Letouzé et al. 2013) in comparison
to PGC and PCCs with other known causative mutations. Methylome clustering of
tumour samples shows that the cluster with hypermethylator features correlates nearly
perfectly with SDH-mutation status. Importantly, these SDH-associated methylome
features correlate with clinical characteristics: younger age at diagnosis and worse
survival, hinting at the functional significance of the altered methylome due to the SDH
mutation.
In a mouse model of SDHB -/- immortalized chromaffin cells, the hypermethylator
phenotype was validated by bisulfite sequencing. Interestingly, while the SDH deficiency
led to a 2-fold decrease in growth rate, it caused increased migration per wound healing
scratch assay. This migration ability was reduced by treatment with decitabine, a known
DNA methyltransferase inhibitor, suggesting that the migratory phenotype was due to
altered methylation induced by succinate accumulation. These characteristics are
consistent with SDH-deficient tumours, which are not associated with increased
proliferation, but rather with increased invasiveness.
Besides globally increased 5mC/5hmC ratio, methylation of lysines 9 and 27 on
histone 3 was reduced in SDH-deficient mouse chromaffin cells, consistent with the fact
that H3K9 and H3K27 methylation are closely linked with DNA methylation (Cedar and
Bergman 2009). These findings were confirmed in tumour samples by
immunofluorescence. Overall, these results suggest that succinate inhibition of a-KGdependent dioxygenases including Tet and JmjC family causes the hypermethylator
phenotype. Functionally, the genome-wide analysis showed significant overlap between
hypermethylated regions and downregulated genes. These genes were much more
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downregulated than in non-hypermethylator tumours, suggesting true functional
significance of hypermethylation in SDH-deficient samples.
Given the relationship between SDH mutations, epigenome, and cancer it is
reasonable to hypothesize that mtDNA mutations can elicit similar phenotypes. While I
found the mtDNA P25L mutation in ND6 decreases survival of mice homozygous for p53
null allele (See Appendix), further studies are required to better characterize this
phenomenon.
Acetyl-CoA metabolism is associated with altered gene expression
Inhibition of ATP-citrate lyase which converts citrate to acetyl-CoA following
export of citrate from the mitochondrion by the citrate/isocitrate carrier (CIC) was shown
to have a marked effect on histone acetylation (Wellen; 2009). However, how global
changes in histone acetylation produce local transcriptional changes is still an open
question. Recently, it has been demonstrated that H3K27ac changes at specific loci in a
glioblastoma model promotes cell adhesion and migration (Lee JV). Additionally,
changes in acetyl-CoA have been associated with upregulation of hypoxia inducible
factor 1-targeted genes, as well as memory-related neuronal genes (Egervari G; 2019)
and genes related to cell cycle progression. This was related to anemia, memory
disorders, and tumour development. Thus, multiple links between acetyl-CoA and gene
regulation emerge in the context of diseases which are known to also be caused by
mtDNA variation.
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Mechanism of locus-specific changes in metabolic modification of histones is unknown
Despite mounting evidence for specific gene signature response to metabolic
alterations affecting the epigenome, the mechanism by which this occurs is still
unknown. For example, while there is evidence that methionine content in diet can alter
eye colour in flies through heterochromatin propagation (Locasale, personal
correspondence), it is unknown whether this trait is affected selectively or accidentally by
modifying large portions of chromatin. On the other hand, even if non-selective,
alteration in chromatin states due to metabolic changes must be an evolutionarily old
mechanism. Therefore, it is possible that traits modifiable by diet and
metabolic/epigenetic changes conferred a selective advantage. Systematic studies of
which genes which are more susceptible to metabolic regulation through the epigenome
may provide insights into signal integration between genes and the environment. In such
models, transcription factors can be treated as enzymes for whom DNA is one of the
substrates. Excess substrate (all chromatin accessible) may preclude transcription
factors binding at the necessary sequences, while no substrate (all chromatin closed)
may limit binding altogether. Likely, the transcriptional output of a cell is a vector sum of
forces including metabolically dictated chromatin state and interactions of the cell with
the environment (e.g. during organ formation and embryo polarization). However, it
seems likely that metabolite-mediated mitochondrial signalling to the epigenome would
be a strong component of the final transcriptional output.
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Conclusions
This study provides evidence that mtDNA variation impacts the epigenome
through metabolic alterations and suggests mechanisms by which these alterations
result in altered gene transcription and disease states. While the mtDNA variation
studied was a particular point mutation in the tRNA, it is likely that the same principle
applies to any mtDNA variation able to produce a significant metabolic deviation. As
demonstrated in mildly heteroplasmic cells, the mtDNA variation need not be drastic to
produce measurable effects on the metabolic output, epigenome and gene transcription.
Also, it is possible that under different conditions, the same mtDNA makeup may
produce different epigenetic outputs. This could explain the context-specific effects seen
for mtDNA haplogroups and point mutations which are adaptive or deleterious
depending on the environment. Finally, the accumulation of somatic tissue mtDNA
mutations could elicit similar metabolic and epigenomic changes and thus may be
important in the acquisition of the metabolic and neurodegenerative phenotypes seen in
aging.
Ultimately, further studies into interactions between energy flow and information
systems may uncover unifying principles to which all living organisms adhere as well as
specific principles on energy and information utilization in human disease states. From a
physician’s perspective, these would be particularly exciting.
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APPENDIX

Effect of mtDNA mutations on cancer
Methods
C57Bl6/JEiJ mice homoplasmic for mtDNA ND6 P25L (Complex I) mutation
(McManus, 2019) were crossed with homozygous null p53 mice and aged. P53 null (ME)
or P53 null ND6 P25L (ND6) male mice were monitored for tumour development and
sacrificed when the tumour size reached 2.5 mm or the mouse was deemed in moribund
condition by the Attending Veterinarian. Survival was compared by Kaplan-Meyer curve.
All procedures were approved by Children’s Hospital of Philadelphia Institutional Animal
Care and Use Committee.

Results
Figure A1. mtDNA ND6 P25L decreases survival of p53 null mice.

Discussion
Addition of mtDNA mutation to p53 null mice resulted in decreased survival due
to increased tumourigenesis. Further survival studies on a larger cohort of animals and
functional studies are necessary to determine the mechanism of this relationship.
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